MyFinsight
Home
Blog
About
Cash and cash
equivalents
$502,512K
(26.35%↑ Y/Y)
Inventory
$52,616K
(-23.71%↓ Y/Y)
Marketable securities
$49,521K
(-0.06%↓ Y/Y)
Accounts receivable, net
$47,545K
(-4.87%↓ Y/Y)
Prepaid expenses and
other current assets
$19,393K
(-4.77%↓ Y/Y)
Other receivables
$3,084K
(-95.54%↓ Y/Y)
Total current assets
$674,671K
(2.90%↑ Y/Y)
Property and equipment,
net
$215,324K
(-10.17%↓ Y/Y)
Intangible assets, net
$61,160K
(315.66%↑ Y/Y)
Operating lease
right-of-use assets
$56,685K
(-9.59%↓ Y/Y)
Other noncurrent
assets
$15,308K
(472.48%↑ Y/Y)
Goodwill
$6,918K
(53.36%↑ Y/Y)
Total assets
$1,030,066K
(5.11%↑ Y/Y)
Total liabilities and
stockholders equity
$1,030,066K
(5.11%↑ Y/Y)
Total stockholders
equity
$825,546K
(6.76%↑ Y/Y)
Total liabilities
$204,520K
(-1.05%↓ Y/Y)
Accumulated deficit
-$1,541,992K
(-5.12%↓ Y/Y)
Additional paid-in capital
$2,367,459K
(5.69%↑ Y/Y)
Total current
liabilities
$118,509K
(5.60%↑ Y/Y)
Operating lease
liabilities, noncurrent
$66,781K
(-13.36%↓ Y/Y)
Deferred revenue,
noncurrent
$9,683K
(-14.08%↓ Y/Y)
Other noncurrent
liabilities
$6,556K
(7.04%↑ Y/Y)
Contingent consideration,
noncurrent
$2,991K
Accumulated other
comprehensive income
$77K
(-65.00%↓ Y/Y)
Common stock
$2K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$30,377K
(-22.24%↓ Y/Y)
Accrued compensation
and related...
$24,744K
(-5.20%↓ Y/Y)
Deferred revenue
$23,610K
(10.08%↑ Y/Y)
Accounts payable
$20,694K
(29.84%↑ Y/Y)
Operating lease
liabilities
$12,015K
(24.26%↑ Y/Y)
Contingent consideration,
current
$7,069K
Back
Back
Balance Sheet
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)
source: myfinsight.com